Effectiveness of a digital health application (levidex) on quality of life in people with multiple sclerosis: A pragmatic, randomized controlled trial (LAMONT)
In a pragmatic randomized controlled trial involving 470 people with multiple sclerosis and impaired quality of life, the digital therapeutic levidex, when added to standard care, significantly improved disease-specific quality of life, depressive symptoms, and social functioning compared to standard care alone.